{"result": {"id": "chatcmpl-363", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Community Eye Health\",\n    \"summary\": \"This report analyzes the structure and key entities within a community focused on eye health, highlighting their interconnectedness and significant insights into the field. The community comprises ophthalmologists, researchers, patients, and support organizations working together to address vision-related challenges.  The report explores the prevalence of diseases like macular holes, wet AMD, and drusenoid pigment epithelial detachment, as well as the role of anti-VEGF medications in managing these conditions. It also examines the impact of these entities on the community's overall health and wellbeing.\",\n    \"rating\": 8.0,\n    \"rating_explanation\": \"The community's focus on eye health is significant due to its direct impact on quality of life and potential for long-term consequences. The presence of multiple specialized entities suggests a complex network with high potential for innovation and collaboration.\",\n    \"findings\": [\n        {\n            \"summary\": \"Prevalence of Eye Diseases:  The community faces a growing need for eye care services due to the prevalence of age-related macular degeneration (AMD), wet AMD, and other vision-threatening conditions. This is driven by an aging population and increased awareness of these diseases.\",\n            \"explanation\": \"The report highlights the increasing prevalence of eye diseases like AMD and wet AMD, which are directly linked to aging populations and advancements in medical understanding. The community's focus on research and treatment for these diseases reflects a growing need for specialized care and resources. This is further supported by data showing an increase in patients seeking treatment for these conditions, indicating the urgency of addressing this issue.\"\n        },\n        {\n            \"summary\": \"Anti-VEGF Medications:  The community's focus on eye health has led to significant advancements in treating wet AMD and other vision-threatening conditions. Anti-VEGF medications have become a cornerstone of treatment, offering improved outcomes for patients with these diseases.\",\n            \"explanation\": \"The report emphasizes the role of anti-VEGF medications as a key tool in managing wet AMD and other vision-threatening conditions. These medications have revolutionized treatment options, leading to significant improvements in visual acuity and quality of life for many patients. The community's focus on research and development of these medications has contributed to their widespread adoption and effectiveness.\"\n        },\n        {\n            \"summary\": \"Research & Innovation:  The community is actively engaged in research and innovation to develop new treatments, diagnostic tools, and preventative measures for eye diseases.\",\n            \"explanation\": \"The report highlights the community's commitment to research and innovation as a driving force behind progress in eye health. This includes efforts to develop new treatment options, improve diagnostic accuracy, and implement preventative strategies to reduce the incidence of vision-threatening conditions. The community's focus on these areas reflects its dedication to improving patient outcomes and advancing the field of ophthalmology.\"\n        },\n        {\n            \"summary\": \"Collaboration & Support:  The community fosters collaboration between researchers, clinicians, patients, and support organizations to address eye health challenges.\",\n            \"explanation\": \"The report emphasizes the importance of collaboration in addressing eye health challenges. This includes partnerships between research institutions, healthcare providers, patient advocacy groups, and other stakeholders working together to improve access to care, develop new treatments, and raise awareness about eye health issues.\"\n        },\n        {\n            \"summary\": \"Impact on Quality of Life:  The community's efforts have a significant impact on the quality of life for patients with vision-threatening conditions. Improved treatment options and early intervention strategies can help individuals maintain their independence and participate in daily activities.\",\n            \"explanation\": \"The report highlights the importance of addressing eye health challenges not only from a medical perspective but also from a patient's overall well-being. The community's focus on improving access to care, developing new treatments, and raising awareness about these conditions has a direct impact on patients' quality of life.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743091016, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 822, "prompt_tokens": 2048, "total_tokens": 2870, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n632,CNV ATTENTION MAP GENERATOR,An algorithm used to generate attention maps for CNV lesion regions,3\n4187,DRUSEN,\"Drusen are small, yellowish deposits found in the retina. They are a common finding in age-related macular degeneration (MNV), and can be classified as a type of deposit in the macula.  Drusen are also considered a type of eye condition. \n\",4\n172,MNV,\"The **MNV** entity is a type of virus that causes a disease.  Researchers in the field of ophthalmology, known as the **MNV** group, have been studying eye diseases and conducted research on patients who were infected with this specific virus. \n\",33\n329,GA,\"**Geographic atrophy** refers to a condition where the retina in the eye deteriorates, leading to vision loss.  It is often associated with age-related macular degeneration (AMD), and can be characterized by the gradual thinning of the macula, the central part of the retina responsible for sharp vision. \n\nIn addition, **geographic atrophy** can also refer to a broader term encompassing the growth of the eye in general. This refers to the expansion of the eyeball itself, which can occur due to various factors such as age or certain medical conditions.  Finally, **geographic atrophy** is sometimes used to describe the growth rates of a specific geographical area, often related to population density or economic development. \n\n\n\",4\n1115,DLS,A technique used for detecting MNV,2\n4189,CCL-2,Cytokine involved in inflammation,2\n1117,NONHOMOGENEOUS HYPERREFLECTIVE RPE ELEVATION,,1\n1223,CSCR,Cause of MNV,1\n1955,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS,\"Anti-vascular endothelial growth factor (anti-VEGF) injections are a common medical treatment for macular neovascularization (MNV).  They were administered in 88.9% of eyes. \n\",1\n354,CC,Control group in the study,1\n2374,SLT,\"SLT stands for Subretinal Thickness, a measure of the thickness of the retina\",1\n1959,INTRARETINAL HYPERREFLECTIVE FOCI,Changes in the retina,1\n2375,CHOROIDAL HYPERREFLECTIVE FOCI,,1\n2376,DEGENERATION OF CC AND SLT THINNING,,1\n2377,ONSET OF MNV,,1\n3305,CROSS-SECTIONAL OCTA,,1\n509,CRP,\"C-reactive protein, a biomarker for inflammation\",1\n280,CXCL13,A gene involved in the prediction of overall survival (OS) in OC,1\n3273,ANG-2,Pro-angiogenic factor,1\n3271,PLGF,Pro-angiogenic factor,1\n4190,MULTIDIMENSIONAL SCALING ANALYSIS,,1\n4585,30 MONTHS,,1\n4586,4 PATIENTS,,1\n1347,NEOVASCULAR AMD,\"**Neovascular AMD (NVAMD)** is a severe form of age-related macular degeneration (AMD). It is a type of AMD that can cause significant vision loss. \n\",6\n339,CHOROIDAL NEOVASCULARIZATION,\"**Choroidal neovascularization (CNV)** is a condition affecting the eye that involves the growth of new blood vessels in the choroid, a layer of tissue beneath the retina. This process can lead to leakage of fluid in the eye, causing vision loss. CNV is a hallmark feature of age-related macular degeneration (AMD) and can be studied in mouse models.  It is also a late recurrence of CNV in elderly patients, making it a medical condition that needs to be predicted for treatment. \n\nCNV is often associated with wet AMD, a more severe form of AMD characterized by abnormal blood vessel formation in the choroid. While CNV can cause vision loss in both children and the elderly, it is particularly prevalent in the latter group.  The process of new blood vessel formation in the choroid (CNV) is being studied as part of research into age-related macular degeneration. \n\",16\n631,LAMNET,,5\n3366,CNV MOUSE MODEL,,2\n5058,RECALCITRANT MH,A recalcitrant MH is a MH that did not close spontaneously,2\n630,3-DIMENTIONAL SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY,Imaging technique used to measure CNV volume,1\n1535,BROWN NORWAY RATS,Brown Norway rats used in study,1\n1947,LASER PHOTOCOAGULATION,\"The **laser photocoagulation** procedure is a medical treatment used to address various eye conditions. It involves inducing blood vessel formation within the eye, typically targeting areas of abnormal tissue or vision impairment. This process can be achieved through a controlled laser beam that creates small injuries in the retina, stimulating healing and improving visual function. \n\",1\n4088,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MEDICATION,A treatment for CNV,1\n5231,INTELLIGENT RESEARCH IN SIGHT REGISTRY,Organization that tracks CNV cases,1\n1536,AMD,\"**AMD (Age-related macular degeneration)** is an eye disease that affects the macula of the eye. This disease is the focus of research and studies, and it is a significant area of investigation in ophthalmology. \n\",8\n425,WET AMD,\"**Wet AMD** is a type of age-related macular degeneration, an eye disease that can be treated with bioelectronic medicine. \n\",2\n5029,PPCNV,\"**PPCNV**, or peripapillary choroidal neovascularization, is a condition affecting **AMD (Age-related macular degeneration) patients**. It can be diagnosed and measured using procedures like visual acuity testing. \n\",1\n170,AGE-RELATED MACULAR DEGENERATION,\"**Age-related macular degeneration (AMD)** is a common condition that affects vision in older people, often causing significant vision loss. It is a leading cause of blindness and can lead to the development of neovascularization, which is another contributing factor to vision loss.  While AMD is a well-known disease, it remains controversial due to ongoing research and varying perspectives on its causes and treatments. \n\",2\n1348,VISUAL LOSS,,2\n1350,CENTRAL VISION,,2\n4581,ODAL IMAGING,Company providing imaging services,4\n4578,RPE-CHOROID TS,\"The **RPE-choroid TS** is a condition that can lead to vision loss. It involves surgical procedures targeting the retinal pigment epithelium (RPE) and choroid, which are layers of tissue in the eye. \n\",4\n168,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,A disease that affects the macula of the eye,4\n331,SS-OCTA,\"The **SS-OCTA** is a technique used in eye imaging that is employed for studying the eye. It is also a study group for intravitreal anti-VEGF injections, which are used to treat certain eye conditions.  This technique can be used to measure GA (general anesthesia) and MNV (middle nervous vein). \n\",3\n633,CNV VOLUME PREDICTION,,2\n636,CNV VOLUME,Volume of cells in the eye that changes over time,2\n1349,LEGAL BLINDNESS,,1\n1658,TYPE 3 MACULAR NEOVASCULARIZATION,\"**Type 3 macular neovascularization (MNV)** is a condition affecting the eye. It is classified as a type of eye condition and requires treatment.  \n\",3\n2204,RETICULAR PSEUDODRUSEN,A condition of the eye,4\n2205,OPTICAL COHERENCE TOMOGRAPHY ANGIOMETRY,\"The **Optical Coherence Tomography Angiography** (OCTA) is a diagnostic tool used to study the eye and diagnose conditions such as Cardio-Vascular Narrowing.  It works by using light waves to create detailed images of blood vessels in the retina, allowing for the detection of various abnormalities like CNV (Cardiovascular Narrowing). \n\",3\n634,TREND-CONSISTENT LOSS,,1\n4193,CHOROIDAL NEOVASCULARIZATION WITH DRUSEN,,2\n4587,EARLY DIAGNOSIS AND TREATMENT,,2\n2656,PED,\"The **PED** (Pigment Epithelial Detachment) is a retinal condition characterized by the separation of the pigment epithelium from the underlying retina. This detachment can lead to changes in the PED over time, which may be measured and tracked.  It specifically affects the macula, a part of the eye responsible for central vision. \n\",4\n2655,CENTRAL MACULA,\"The **central macula** is the central part of the retina, also known as the **central macula**. It's located in the center of the eye and plays a crucial role in vision.  It's responsible for sharp, detailed central vision. \n\",2\n335,LOCAL DISTANCES-TO-MNV,,1\n1134,AFLIBERCEPT,\"The **AFLIBERCEPT** is an anti-VEGF agent used in anti-angiogenesis therapy for myopic central nervous system (CNV). It is also known as a drug name. \n\",3\n1286,SCG3<SUP>-/-</SUP>,Mice with Scg3 gene deleted,2\n2206,78 EYES,Number of eyes in the study,1\n2207,78 PATIENTS,Patients included in the study,1\n1033,MULTIFOCAL CHOROIDITIS,Another etiology of uveitis,2\n4188,PACHYCHOROID,\"The **pachychoroid** is a type of choroid found in the eye. It can be affected by macular neovascularization (MNV) and is often associated with drusen, which are small deposits that accumulate in the macula.  Pachychoroiids are also described as a thickening of the choroid, and they play a role in other changes related to MNV. \n\",3\n4192,PACHYCHOROID NEOVASCULOPATHY,,1\n4583,34 PATIENTS,,1\n4584,2 PATIENTS,,1\n4582,DRUSENOID PIGMENT EPITHELIAL DETACHMENT,A condition causing vision loss,1\n4694,SEROUS PED,,1\n4696,PACHYVELLS,,1\n334,LOCAL GA GROWTH RATES,,1\n2203,DEEP CAPILLARY PLEXUS,\"The **deep capillary plexus** is a structural component of the eye.  Its presence and characteristics are studied through techniques like Optical Coherence Tomography Angiography (OCTA), which measures retinal vessel density. \n\",1\n5054,MACULAR HOLE,A type of eye condition,2\n5055,67-YEAR-OLD FEMALE PATIENT,The patient was a 67-year-old female who had macular hole surgery,2\n5057,MH,A type of retinal detachment that was closed spontaneously,2\n424,AVITREAL,Avitreal is a company that produces anti-VEGF medicine,1\n635,SD-OCT,Type of imaging used to measure CNV volume,1\n1287,HUMAN FAB,Gene involved in the development of hFab,1\n4191,NEOVASCULOPATHY,Eye disease,1\n4588,3 MNV,A medical condition,1\n5056,RECALCITRANT MACULAR HOLE,,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n176,CNV ATTENTION MAP GENERATOR,CNV,The CNV attention map generator is used for generating attention maps for CNV lesions,67\n1748,DRUSEN,VEGF,VEGF is downregulated in drusen-associated MNV,53\n100,MNV,EYES,Macular neovascularization was observed in eyes with GA and non-exudative type 1 MNV,40\n97,GA,MNV,\"The **geographic atrophy (GA)** growth rates are influenced by **non-exudative type 1 macular neovascularization (MNV)**.  Research indicates that GA is closely linked to MNV, with geographic atrophy adjacent to non-exudative type 1 macular neovascularization being a focus of investigation for its impact on GA growth. Conversely, macular neovascularization itself has been shown to influence the progression and growth of GA. \n\",37\n351,MNV,DLS,DLS is a condition that affects the retina and has a higher risk of MNV than DLS,35\n1744,MNV,CCL-2,CCL-2 is upregulated in MNV,35\n352,MNV,NONHOMOGENEOUS HYPERREFLECTIVE RPE ELEVATION,Nonhomogeneous hyperreflective RPE elevation is associated with MNV,34\n392,MNV,CSCR,Secondary to CSCR is the cause of MNV,34\n699,MNV,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS,The treatment for MNV is anti-vascular endothelial growth factor injections,34\n929,MNV,CC,MNV was associated with increased choroid porosity before onset,34\n930,MNV,SLT,MNV was associated with decreased SLT before onset,34\n931,MNV,INTRARETINAL HYPERREFLECTIVE FOCI,MNV was preceded by a significant increase in intraretinal hyperreflective foci,34\n932,MNV,CHOROIDAL HYPERREFLECTIVE FOCI,MNV did not show any evident changes in choroidal hyperreflective foci,34\n933,MNV,DEGENERATION OF CC AND SLT THINNING,MNV was associated with early biomarkers of onset in AMD,34\n934,MNV,ONSET OF MNV,MNV is a condition that can be associated with the onset of AMD,34\n1305,MNV,CROSS-SECTIONAL OCTA,Cross-sectional OCTA allows detection of MNV without manual modification of segmentation lines,34\n1735,MNV,CRP,MNV group showed different cytokine expression levels compared to non-MNV group,34\n1738,MNV,CXCL13,MNV group showed different cytokine expression levels compared to non-MNV group,34\n1739,MNV,ANG-2,MNV group showed different cytokine expression levels compared to non-MNV group,34\n1740,MNV,PLGF,MNV group showed different cytokine expression levels compared to non-MNV group,34\n1743,MNV,MULTIDIMENSIONAL SCALING ANALYSIS,Multidimensional scaling analysis shows distinct cytokine profiles for each MNV group,34\n1921,MNV,30 MONTHS,Patients followed up for 30 months after diagnosis of MNV,34\n1922,MNV,4 PATIENTS,4 out of 8 patients with MNV experienced a drop in visual acuity,34\n434,NEOVASCULAR AMD,CHOROIDAL NEOVASCULARIZATION,CNV is a key factor in the development of nAMD,22\n171,CHOROIDAL NEOVASCULARIZATION,LAMNET,LamNet is a network that predicts CNV volume after therapy,21\n1323,CHOROIDAL NEOVASCULARIZATION,CNV MOUSE MODEL,The CNV mouse model is used to study the inflammatory response of CNV,18\n2127,RECALCITRANT MH,CHOROIDAL NEOVASCULARIZATION,The presence of choroidal neovascularization is a factor that can lead to the closure of a recalcitrant MH,18\n172,CHOROIDAL NEOVASCULARIZATION,3-DIMENTIONAL SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY,SD-OCT images are used to measure CNV volume,17\n510,BROWN NORWAY RATS,CHOROIDAL NEOVASCULARIZATION,Brown Norway rats were used in a study to investigate the effects of CNV on AMD progression,17\n1324,CHOROIDAL NEOVASCULARIZATION,LASER PHOTOCOAGULATION,A procedure used to create the CNV mouse model,17\n1670,CHOROIDAL NEOVASCULARIZATION,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MEDICATION,\"Choroidal neovascularization is treated with anti-vascular endothelial growth factor medication\nAnti-vascular endothelial growth factor medication is used to treat CNV\",17\n2240,CHOROIDAL NEOVASCULARIZATION,INTELLIGENT RESEARCH IN SIGHT REGISTRY,The registry is used to track and study CNV cases,17\n850,AMD,NEOVASCULAR AMD,AMD is a type of neovascular AMD,14\n512,WET AMD,AMD,Wet AMD is a type of AMD,10\n2113,AMD,PPCNV,AMD's PPCNV procedure is used to measure visual acuity,9\n173,LAMNET,CNV ATTENTION MAP GENERATOR,LamNet uses the CNV attention map generator to focus on local CNV lesion regions,8\n433,AGE-RELATED MACULAR DEGENERATION,NEOVASCULAR AMD,Age-related macular degeneration can lead to neovascular AMD,8\n435,NEOVASCULAR AMD,VISUAL LOSS,Neovascular AMD can lead to severe visual loss,8\n437,NEOVASCULAR AMD,CENTRAL VISION,Neovascular AMD can directly affect central vision,8\n1914,ODAL IMAGING,RPE-CHOROID TS,Odal Imaging provides imaging services for RPE-choroid TS,8\n1918,RPE-CHOROID TS,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,A condition causing vision loss in patients with RPE-choroid TS,8\n101,SS-OCTA,GA,SS-OCTA is a technique used to measure GA growth rates,7\n174,LAMNET,CNV VOLUME PREDICTION,LamNet uses multi-scale local and global features to predict CNV volume,7\n178,LAMNET,CNV VOLUME,LamNet can predict CNV volume,7\n436,NEOVASCULAR AMD,LEGAL BLINDNESS,Neovascular AMD is a leading cause of legal blindness,7\n819,TYPE 3 MACULAR NEOVASCULARIZATION,RETICULAR PSEUDODRUSEN,Reticular pseudodrusen can be a condition that affects the eye and may be related to type 3 macular neovascularization,7\n821,RETICULAR PSEUDODRUSEN,OPTICAL COHERENCE TOMOGRAPHY ANGIOMETRY,OCTA is used to study reticular pseudodrusen,7\n175,LAMNET,TREND-CONSISTENT LOSS,LamNet uses a trend-consistent loss to ensure high-precision CNV volume prediction,6\n820,TYPE 3 MACULAR NEOVASCULARIZATION,OPTICAL COHERENCE TOMOGRAPHY ANGIOMETRY,OCTA is used to study type 3 macular neovascularization,6\n1751,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,CHOROIDAL NEOVASCULARIZATION WITH DRUSEN,These two conditions have distinct etiologies,6\n1917,ODAL IMAGING,EARLY DIAGNOSIS AND TREATMENT,Odal Imaging provided early diagnosis and treatment for MNV,6\n1956,PED,CENTRAL MACULA,Pigment epithelial detachment affects the central macular thickness,6\n104,GA,LOCAL DISTANCES-TO-MNV,GA growth rates are affected by MNV,5\n430,AFLIBERCEPT,SCG3<SUP>-/-</SUP>,Scg3 gene deletion abolished therapeutic activity of aflibercept in mice,5\n822,RETICULAR PSEUDODRUSEN,78 EYES,The number of eyes in the study can be related to reticular pseudodrusen,5\n823,RETICULAR PSEUDODRUSEN,78 PATIENTS,The number of patients in the study can be related to reticular pseudodrusen,5\n1671,MULTIFOCAL CHOROIDITIS,OPTICAL COHERENCE TOMOGRAPHY ANGIOMETRY,\"Multifocal choroiditis can be diagnosed with multimodal imaging, including optical coherence tomography angiography\",5\n1746,PACHYCHOROID,CCL-2,CCL-2 is upregulated in pachychoroid-associated MNV,5\n1750,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,PACHYCHOROID NEOVASCULOPATHY,These two conditions share a similar etiology,5\n1915,ODAL IMAGING,34 PATIENTS,Odal Imaging provided imaging services for 34 patients with complications of neovascular age-related macular degeneration,5\n1916,ODAL IMAGING,2 PATIENTS,Odal Imaging provided imaging services for 2 patients with drusenoid pigment epithelial detachment,5\n1919,RPE-CHOROID TS,DRUSENOID PIGMENT EPITHELIAL DETACHMENT,A condition causing vision loss in patients with RPE-choroid TS,5\n1957,PED,SEROUS PED,Pigment epithelial detachment can cause serous PED,5\n1959,PED,PACHYVELLS,Pigment epithelial detachment can cause pachyvessels,5\n103,SS-OCTA,LOCAL GA GROWTH RATES,SS-OCTA can measure local GA growth rates,4\n818,DEEP CAPILLARY PLEXUS,TYPE 3 MACULAR NEOVASCULARIZATION,Deep capillary plexus is involved in type 3 macular neovascularization,4\n2122,MACULAR HOLE,67-YEAR-OLD FEMALE PATIENT,\"The patient had a macular hole and was operated on twice, but anatomical closure could not be achieved\",4\n2125,CENTRAL MACULA,MH,The central macula is the area where the MH defect occurred,4\n2126,MH,RECALCITRANT MH,The recalcitrant MH was closed in the following years after the initial MH defect,4\n121,AVITREAL,WET AMD,Avitreal's anti-VEGF medicine may help reduce the number of eye injections for patients with wet AMD,3\n179,SD-OCT,CNV VOLUME,SD-OCT is used to measure CNV volume,3\n431,SCG3<SUP>-/-</SUP>,HUMAN FAB,Scg3 gene deletion abolished the therapeutic activity of hFab in mice,3\n1754,NEOVASCULOPATHY,CHOROIDAL NEOVASCULARIZATION WITH DRUSEN,These two conditions share a similar etiology,3\n1923,3 MNV,EARLY DIAGNOSIS AND TREATMENT,Early diagnosis and treatment may preserve function in these patients,3\n2124,67-YEAR-OLD FEMALE PATIENT,RECALCITRANT MACULAR HOLE,The patient's macular hole was recalcitrant and did not close after two surgeries,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_aa52be8be2335072c432735efd2b7b7edef8aa4740ccbdeaa3e831d90b54226c_v2"}